Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-05

Clinical Trial Update: Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients [NA]

View source ↗

Summary

This document provides an update on a clinical trial evaluating infliximab in combination with classic DMARDs for rheumatoid arthritis. No phase or current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Zhang, Xiao, M.D. | Conditions: Rheumatoid Arthritis(RA) | NA | Status: UNKNOWN